Adalimumab therapy for refractory birdshot chorioretinopathy

Conclusion: The results suggest that adalimumab is effective at improving visual acuity and at tapering concomitant immunomodulatory therapy, in patients with refractory birdshot chorioretinopathy. However, complete remission is rarely achieved.
Source: RETINA - Category: Opthalmology Tags: Original Study Source Type: research